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Flexible Coping Psychotherapy for Functional Dyspeptic Patients:
A Randomized, Controlled Trial
CECILIA CHENG, PHD, FENG-CHI YANG, MD, SONG JUN, MD, AND JANE M. HUTTON, PHD
Objective: This study tested the efficacy of a new psychotherapy, flexible coping psychotherapy (FCP), specifically designed for
enhancing coping flexibility of patients with functional dyspepsia (FD). The design of this psychotherapy is based on the general
cognitive–behavioral model and previous findings on FD. Methods: We adopted a randomized, controlled design to examine the
differences between the target (FCP) and control (supportive psychotherapy [SPP]) conditions. Coping flexibility and outcome
measures reported by 75 Chinese FD patients (18–65 years; 35% men) were assessed before and 12 months after treatment.
Results: Results revealed that participants who received the FCP reported an increase in coping flexibility as well as reductions
in self-rated dyspeptic symptom severity (SDSS), gastroenterologist-rated dyspeptic symptom severity, and anxiety levels (p
values .01). Participants who received the SPP reported reductions in SDSS and anxiety levels (p values.0001). Although both
groups reported a decrease in SDSS, only the SDSS level of the FCP group was comparable to that of a healthy community sample
(p  .28). Conclusions: These findings suggest that FCP is a potentially effective intervention for treating FD symptoms. Its
effectiveness may be attributable to the specific components of FCP rather than common psychotherapeutic factors such as emotional
support and empathy per se. Key words: anxiety, coping, functional dyspepsia, psychotherapy, randomized controlled trial, stress.
CFQ  Cognitive Flexibility Questionnaire; DSQ  Dyspeptic
Symptom Questionnaire; FCP  flexible coping psychotherapy;
FD  functional dyspepsia; GDSS  gastroenterologist-rated dys-
peptic symptom severity; MANOVA  multivariate analysis of
variance; RCI reliable change index; SDSS self-rated dyspeptic
symptom severity; SPP  supportive psychotherapy; STAI  State-
Trait Anxiety Inventory.
INTRODUCTION
A ccording to the Rome II Diagnostic Criteria (1), func-tional dyspepsia (FD) is a functional problem with pain or
discomfort centered in the upper abdomen for at least 12
weeks within 1 year without any structural or biochemical
causes identified. The current standard treatment of FD is
medical, emphasizing pharmacological interventions and di-
etary changes (2). It is worth noting that few drugs and dietary
plans have beneficial effects, and most patients with FD are
not responsive to medical treatment (see (3)).
Compared with studies evaluating medical treatment, the
number of studies examining the efficacy of psychotherapy on
FD is relatively scant. Although there is growing evidence
indicating the therapeutic value of psychotherapy—such as
supportive psychotherapy and cognitive psychotherapy—on
FD (see (4,5)), a critical review of this body of research
revealed that most therapists adopted therapies designed for
treating other psychological problems. The rationale given to
the type of psychotherapy selected was unknown. To date, no
studies have adopted systematic models or empiric findings as
foundations in designing specific treatment programs for FD.
To fill this knowledge gap, we designed a new psychotherapy.
This psychotherapy differs from the existing FD therapies in
its design, which is based on both the general cognitive–
behavioral model and a body of studies on FD.
Description of Flexible Coping Psychotherapy
Previous studies (6–8) have shown that patients with FD
are characterized by an active inflexible coping style. Specif-
ically, they tend to use problem-focused coping regardless of
the controllability of stressful situations. Although problem-
focused coping strategies are generally adaptive in mitigating
anxiety and depression (e.g., (9,10)), these strategies can also
magnify such psychological distress (e.g., (8,11)). On the
other hand, studies (6–8,12) revealed that emotion-focused
coping, rather than problem-focused coping, is associated with
less severe physical symptoms. We proposed the need to bal-
ance the active inflexible coping style of patients with FD by
strengthening their use of emotion-focused coping strategies.
It is worth noting that the mere acquisition of skills may not
necessarily lead to symptom relief, especially for long-term
changes that last for more than 6 months after treatment. To
foster long-term reduction in symptom severity, clients may
have to understand how to a) deploy different strategies to
cope with the specific demands of a variety of problems, and
b) translate the skills learned in the treatment program into
practical strategies for handling real-life problems. Previous
studies on coping flexibility (13–15) revealed that problem-
focused coping is more effective in mitigating distress in
controllable situations, whereas emotion-focused coping is
more effective in mitigating distress in uncontrollable situa-
tions. Apart from acquiring various types of fundamental
skills (coping strategies) to handle stress, the flexible coping
psychotherapy (FCP) advocates the acquisition of a “metaskill”
of discriminative facility (see (14,16)). Specifically, this
“metaskill” targets at a) sharpening their sensitivity in distin-
guishing among distinct demands of diverse situations, and b)
increasing their flexibility to use distinct fundamental skills in
different situations and symptom conditions.
Overview of This Study
This study was conducted to test the effectiveness of the
proposed FCP. To identify which specific treatment compo-
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nents were responsible for symptom relief, we compared the
FCP with supportive psychotherapy (SPP). Instead of includ-
ing a no-treatment or waiting list control group, we chose SPP
to control for the amount of time and attention spent on
clients. A randomized, controlled design was adopted to com-
pare the differences between the target treatment condition
(FCP) and the control treatment condition (SPP). Each of
these conditions comprises six 1-hour biweekly sessions over
a period of 12 weeks.
The two treatment conditions were compared with examine
whether the FCP would have therapeutic effects on coping
flexibility and outcome changes independent of the time and
attention spent with the clients. For the outcome analyses, the
most common measure was self-rated dyspeptic symptom
severity (SDSS; see e.g., (17,18)), and this variable was in-
cluded as the a priori primary outcome variable. Secondary
outcome variables include gastroenterologist-rated dyspeptic
symptom severity (GDSS) and anxiety levels (see (19)). In
this study, therapeutic effects were operationalized as a) in-
crease in coping flexibility, b) reduction in SDSS and GDSS,
and c) decrease in anxiety levels. The variables of coping
flexibility, SDSS, GDSS, and anxiety levels were assessed
before and 12 months after the psychotherapy.
METHODS
Participants
Figure 1 depicts the course of patients through the various phases of this
study. We performed an a priori power test (20), which showed that at least
29 participants should be allocated into each of the two treatment conditions
to yield 90% power (p  5%, two-tailed). Taking both rejection and dropout
rates into consideration, we initially recruited 150 Chinese adults with FD
between August 2003 and September 2004. These potential participants were
randomly chosen from a registration list of patients with FD recruited from the
gastroenterology section of a university teaching hospital and a general
hospital in Beijing, China.
All the participants met the Rome II Diagnostic Criteria (1) with dyspeptic
symptoms for at least 12 weeks within 1 year but without endoscopic
evidence of peptic ulcer disease, gastric cancer, gastritis, or esophagitis. These
functional dyspeptic symptoms refer to epigastric pain and discomfort (e.g.,
belching, nausea, retching, vomiting). Also, they were diagnosed as endo-
scopically normal. Fifty-six patients were excluded because they met at least
one of the following exclusion criteria: a) had received medical treatment for
less than 3 years, b) had symptoms of irritable bowel syndrome, c) had
heartburn or acid regurgitation, d) had undergone a surgery, e) had a history
of serious physical and psychiatric illness,1 f) were pregnant, g) were under 18
year old, and h) were unwilling to give written informed consent.
Eligible participants were assigned to a treatment condition through
concealed allocation. An independent research assistant, who was not directly
involved in the conduct of various phases of the study, carried out the
allocation process. Each of the 75 participants who met the inclusion criteria
was assigned a number randomly generated by a computer program. Then the
research assistant performed the randomization through which 38 participants
were assigned to the target treatment condition and 37 were assigned to the
control condition. Before participants signed the consent form, all were
informed that the treatment had not yet been tested, so it might or might not
be beneficial, and the sessions would be audiotaped to ensure the quality of
treatment. The protocol of this study obtained prior approval from the Human
Subject Research Panel of the university with which the first author was
affiliated.
Eleven participants, five from the target group and six from the control
group, dropped out (see Fig. 1). Participants who completed both phases of
the study and those who dropped out in the second phase did not differ in any
of the time 1 measures (F (3, 71)  0.36, p  .78).
For the final sample, the target group comprised 33 participants (12 males,
21 females), and the control group contained 31 participants (9 males, 22
females). The average age in the target and the control groups was 39.06 years
(standard deviation [SD]  11.25, range  21–62 years) and 41.81 years
(SD  13.09, range  18–65 years), respectively. For the target group, 7%
had less than a high school education, 59% were high school graduates, and
34% were undergraduates or university graduates. For the control group, 8%
had less than a high school education, 62% were high school graduates, and
30% were undergraduates or university graduates. Participants of the two
groups did not statistically differ in the distribution of sex (2 (1) 0.16, p
.69), age group (2 (4)  2.00, p  .74), and education level (2 (3)  3.11,
p  .38). The two groups also did not statistically differ in the number of
years of having FD (F (1, 73)  0.60, p  .44; mean  4.87 and SD  1.96
for the FCP group; mean  5.25 and SD  2.26 for the SPP group). All
participants underwent a six-session psychotherapy program with the same
therapist. They met the therapist individually for 1 hour biweekly for 12
weeks.
The multivariate analysis of variance (MANOVA) results revealed that
none of the main and interaction effects among the demographic variables
were statistically significant (F values 1.01, p values .45). The demo-
graphic variables were thus excluded in the subsequent statistical analyses.
Treatment Conditions
The FCP was adapted from a manualized model for patients with FD (21).
The aims, framework, and scripts of each psychotherapy session were written
in the manual and the therapist was advised to refer closely to the manual for
standardization of practice. The first session included a) psychoeducation
about the prevalence and nature of FD, and b) discussion about sources of
stress and how they influence dyspeptic symptoms. Participants were then
taught a variety of problem-focused and emotion-focused coping strategies in
the next three sessions. In the subsequent sessions, participants were taught
1Serious physical and psychiatric illness refers to any illnesses that require
medical attention for over 6 months.
Figure 1. Flow diagram showing course of participants through various
phases of the study. FCP  flexible coping psychotherapy; SPP  supportive
psychotherapy.
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the “metaskill” of discriminative facility, that is, how to a) distinguish among
the distinct characteristics of diverse stressful situations, and b) flexibly
deploy various strategies learned in the previous sessions to handle life stress
with specific demands and distinct levels of symptom severity. For instance,
participants were taught to distinguish the extent of controllability of different
stressful situations, and to deploy a) problem-focused coping when the out-
come of a situation was deemed controllable and b) emotion-focused coping
when the outcome was deemed uncontrollable. Participants were asked to
practice these techniques and skills at home and to note any difficulties in
using the techniques and skills on their own. Such difficulties in application
were discussed in the next session.
The SPP (see (22)) was adopted to control the time, attention, and
sympathy received by the participants in the target group. The contact time of
this control treatment matched exactly that of the target treatment. In each
psychotherapy session, participants were asked to express their feelings and
distress related to their functional dyspeptic symptoms. They also received
information about the prevalence and nature of FD. The therapist was in-
structed not to use any of the specific elements of the FCP in the control
psychotherapy sessions.
Therapist
The psychotherapy sessions were conducted by a certified clinical psy-
chologist with 4-year postdoctoral clinical experience. This therapist has
received training in both cognitive–behavioral and person-centered psycho-
therapies, and believed that both types of psychotherapy were equally valid
and useful to patients with functional dyspepsia. The same clinical psychol-
ogist delivered the psychotherapy for both FCP and SPP to eliminate the
possibility of treatment differences resulting from different therapist effects.
The sessions were supervised by an experienced clinical psychologist on a
regular basis, and the amount and process of supervision were identical for the
FCP and SPP sessions. All the sessions were audiotaped and randomly
selected for reviews to ensure standardization of practice and fulfillment of
ethical requirements.
Therapist Adherence to Treatment Condition
One session was randomly selected from each participant’s psychotherapy
and was rated by two independent raters to check whether the therapist’s
practice had adhered to a specific treatment condition specified by the
psychotherapy manual. The kappa (23), a common measure of interrater
agreement, showed good agreement among the raters (  0.88). Ninety-six
percent of the rated sessions were correctly assigned to the treatment condi-
tion from which they were drawn. The wrongly allocated sessions were
typically found in the first session for which the two treatment conditions
were very similar.
Measures
In this study, a set of questionnaires, which comprises the Cognitive
Flexibility Questionnaire (CFQ), Dyspeptic Symptom Questionnaire (DSQ),
and State-Trait Anxiety Inventory (STAI), was given to each participant
before (time 1) and 12 months after (time 2) the treatment. These measures
were administered by a research nurse at each time point. The therapist, super-
visor, and gastroenterologists did not have access to the participants’ data.
The CFQ (13) was used to examine coping flexibility. Participants were
instructed to describe two controllable and two uncontrollable hassling events
experienced in the past 6 months. They were then asked to report all the
strategies deployed to handle each event and then to classify each strategy into
one of two goals: “strategy used for managing the event” (i.e., problem-
focused) and “strategy used for regulating the emotion associated with the
event” (i.e., emotion-focused). Coping flexibility is operationalized by a
strategy–situation fit index, which reflects the extent of situation-appropriate-
ness of coping patterns. The scoring criterion derived from the goodness-of-fit
theories (24,25) was adopted. A score of 1 was given to the use of a)
problem-focused coping in a controllable stressful situation, or b) emotion-
focused coping in an uncontrollable stressful situation. A score of 0 was given
to the use of a) problem-focused coping in an uncontrollable stressful situa-
tion, or b) emotion-focused coping in a controllable stressful situation. Be-
cause there are considerable individual differences in the number of coping
strategies used, the scores were aggregated and then divided by the total
number of coping strategies. The index ranges from 0 (not flexible at all) to
1 (extremely flexible). The CFQ displayed good reliability, criterion-related
validity, and discriminant validity (13,14,26).
The DSQ (26,27) was used to assess both SDSS and GDSS. This ques-
tionnaire assesses four main symptoms (i.e., epigastric pain, belching, nausea,
and vomiting) commonly reported by patients with FD (27). Respondents
rated the perceived severity of each symptom along an 11-point scale, which
ranges from 0 (not severe at all) to 10 (extremely severe). The four items were
aggregated to form a symptom severity score, which ranges from 0 to 40. A
higher score indicates a higher level of SDSS. This measure was found to be
reliable and has good discriminant validity among patients with FD in Hong
Kong (8,26–28).
The DSQ was completed by not only the participants, but also gastroen-
terologists. Two gastroenterologists, each with more than 5 years of clinical
experience, rated the questionnaire independently to yield the GDSS scores.
Both of them have seen the participants for more than 2 years. Interrater
agreement was high (  0.91). This measure has good internal consistency
and discriminant validity among Chinese patients with FD (6,27). In this
study, both self- and gastroenterologist ratings displayed good internal con-
sistency (Cronbach   0.83 and 0.85).
The STAI (29,30) was used to assess levels of anxiety. The T-Anxiety
subscale, which comprises 20 statements, was adopted to measure trait
anxiety. The anxiety scores range from 20 to 80 with a higher score indicating
a higher trait anxiety level. This measure has been found reliable and valid in
Chinese samples (29,31). The items were also found to be internally consis-
tent in this study (Cronbach   0.91).
Blinding
Blinding was carried out at four different levels: a) the therapist who
delivered the psychotherapy sessions and research nurse who delivered the
questionnaire; b) gastroenterologists and endoscopists who performed the
endoscopy and made diagnoses; c) research assistants who performed adher-
ence ratings of psychotherapy sessions, data entry, and statistical analyses;
and d) participants with FD. The therapist and research nurse were blind to the
research hypotheses, participants’ medical histories, and participants’ self-
rated symptoms. The gastroenterologists and endoscopists were blind to the
research hypotheses, the treatment condition to which participants were
assigned, and participants’ self-rated symptoms. The research assistants were
blind to the research hypotheses, the treatment condition to which participants
were assigned, and participants’ medical histories. The participants were blind
to the research hypotheses and the treatment condition to which they were
assigned.
Procedure
Participants had to give informed consent before the study began. After
giving written consent, participants completed a set of questionnaires distrib-
uted by a research nurse. At the follow-up phase, the same set of question-
naires was mailed to participants, and a return envelope was provided for the
completed questionnaires. Reminder notes were sent to those participants who
did not return the questionnaire within 2 and 4 weeks, respectively. A
debriefing note was sent to all participants after they had returned the
questionnaires. Participants in the SPP condition were invited to take part in
an upcoming FCP if interested.
Statistical Analyses
Before performing the main analyses, we first examined the interrelation-
ships among the variables with Pearson product-moment correlation coeffi-
cients. Then we scrutinized longitudinal changes in coping flexibility and
outcome variables between the groups over the 12-month period. We adopted
a 2 (group: target versus control)  2 (time: pre- versus posttreatment)
mixed-design (split plot) MANOVA with group as a between-participants
variable and time as a repeated measure. A significant group  time inter-
action indicates that the extent of changes in a variable is statistically different
between the two treatment groups.
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Apart from examining statistical effects of treatment outcomes, clinically
significant changes should also be evaluated. Two sets of clinical significance
analyses were conducted to assess the practical value regarding the clinical
effects of a treatment. The first set identifies the level of changes induced by
a treatment. Reliable change index (RCI) (32) was calculated for this purpose
because this method of comparison has been found valid in distinguishing
reliable from unreliable changes in treatment outcomes (e.g., (33,34)).
The second set assesses the clinical meaningfulness of the changes in the
primary outcome, which is operationalized by equivalent posttreatment SDSS
scores between a treatment group after attending psychotherapy and a non-
clinical group. Normative comparisons (35) were performed because these
procedures provide a robust test of treatment efficacy by a norm or criterion
independent of the clinical samples.
RESULTS
Relationships Between Coping Flexibility and
Outcome Measures
Table 1 shows that the correlation coefficients among the
study variables. Time 1 coping flexibility was inversely re-
lated to time 1 anxiety and time 2 anxiety. Time 2 coping
flexibility was also inversely related to time 2 SDSS and time
2 anxiety. Although these results suggest that greater flexibil-
ity in coping is related to reductions in FD symptoms, it is
worth noting that coping flexibility was unrelated to SDSS at
time 1. The association between coping flexibility and FD
symptoms was statistically significant only after the partici-
pants had received psychotherapy.
Additional correlational analyses were conducted to exam-
ine changes in coping flexibility and changes in symptoms
over time. Results showed that changes in coping flexibility
were inversely related to both changes in SDSS and changes
in GDSS (rs (64)  0.39 and 0.37, ps  .002). The
inverse association between changes in coping flexibility and
changes in anxiety was not statistically significant (r (64) 
0.20, p  .11).
Longitudinal Analyses of Changes in
Coping Flexibility
Table 2 presents descriptive statistics for each time point
for the group of participants who received FCP (treatment
group) and the group of participants who received SPP (con-
trol group). For coping flexibility, the MANOVA results
showed that the main effects of group and time were both
statistically significant (F values (1, 62)  8.38 and 9.51,
mean standard errors [MSEs]  0.10 and 0.08, p values
.003). These statistically significant main effects should be
interpreted in light of the statistically significant interaction
between group and time (F (1, 62)  6.80, MSE  0.08, p 
.01). Such results indicate that the target group displayed
greater flexibility in coping, but the control group showed no
changes in coping flexibility from time 1 to time 2.
Longitudinal Analyses of Outcome Changes
For SDSS, there were statistically significant main effects
of group and time (F values (1, 62)  48.40 and 457.10,
MSEs  21.91 and 10.80, p values .0001). The group 
time interaction effect was also statistically significant (F (1,
62)  68.61, MSE  10.80, p  .0001). From time 1 to time
2, both the target and the control groups reported a reduction
in SDSS, but the target group reported a greater extent of
reduction than did the control group.
For GDSS, results revealed statistically significant main
effects of group and time (F values (1, 62)  23.65 and
197.75, MSEs  25.39 and 7.38, p values .0001). The
group  time interaction effect was statistically significant
(F (1, 62)  62.18, MSE  7.38, p  .0001). Such results
indicate that there was a decrease in GDSS for both the target
and the control groups, but the extent of reduction was greater
for the target group.
For anxiety, the main effect of time was statistically sig-
nificant (F (1, 62)  482.94, MSE  45.87, p  .0001). This
result indicates that from time 1 to time 2, both groups
reported a similar reduction in anxiety levels.
Clinical Significance of Change
Reliable Change Identification
The RCI was calculated to indicate the amount of change
that occurred after a treatment for each of the outcome mea-
sures. A value greater than or equal to 1.96 indicates a reliable
change in treatment outcomes (see (32)). The right panel of
Table 1 summarizes the RCI for each treatment outcome for
the two treatment groups. The FCP produced reliable changes
in the treatment outcomes. The SPP also produced reliable
changes in the treatment outcomes with the exception of
GDSS.
TABLE 1. Zero-Order Correlation Coefficients for Study Variables (N for time 1  75, N for time 2  64)
2 3 4 5 6 7 8
1. Coping flexibility—time 1 0.14 0.01 0.50b 0.12 0.03 0.19 0.31a
2. SDSS—time 1 — 0.47b 0.53b 0.21 0.31a 0.52b 0.44b
3. GDSS—time 1 — 0.26a 0.19 0.18 0.43b 0.26a
4. Anxiety time 1 — 0.17a 0.12 0.42b 0.66b
5. Coping Flexibility—time 2 — 0.44b 0.15 0.31b
6. SDSS—time 2 — 0.62b 0.10
7. GDSS—time 2 — 0.30a
8. Anxiety—time 2 —
a p  .05.
b p  .01.
SDSS  self-rated dyspeptic symptom severity; GDSS  gastroenterologist-rated dyspeptic symptom severity.
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Normative Comparisons
Normative comparisons evaluate the efficacy of a treatment
in relieving dyspeptic symptoms with a criterion independent
of clinical samples. However, no published norms were avail-
able for the outcome measure of dyspeptic symptom severity.
Following the suggestions by Kendall and colleagues, we used
data drawn from a community sample of healthy Chinese as
reported in another study (6). In that study, 83 Chinese healthy
participants, defined as having no major health problems
within the past 5 years, completed the same measure. The
mean SDSS score of this sample was 7.65 (SD  8.78).
Kendall and colleagues recommended the adoption of 1 SD
() for defining the range of closeness within which a treat-
ment group and the nonclinical group is deemed clinically
equivalent. The upper bound of the normative range was 16.43
(i.e., 7.65  ). Figure 2 depicts the SDSS scores for the FCP
and SPP groups across the two phases of this study along with
the normative range for normative comparisons.
After specifying the range of closeness, we conducted both
a clinical equivalency test and a traditional t test (i.e., inde-
pendent-samples t test) to determine whether a treatment pro-
duced changes such that clients who received treatment are
similar to the nonclinical norms. The clinical equivalency test
examines whether the mean difference between a treatment
group and the healthy community group lies within the spec-
ified range of closeness. Results showed that the difference
TABLE 2. Descriptive Statistics and Reliable Change Index for Study Variables
Treatment Group
Time 1
(N  75)
Time 2
(N  64)
RCI
Mean SD
95% Confidence
Interval
Mean SD
95% Confidence
Interval
Coping flexibility Flexible coping psychotherapy 0.27 0.32 (0.16–0.38) 0.56 0.35 (0.46–0.66) 2.36a
Supportive psychotherapy 0.24 0.31 (0.13–0.36) 0.27 0.21 (0.16–0.37) 0.08
SDSS Flexible coping psychotherapy 28.64 3.38 (27.31–29.96) 11.39 4.03 (9.91–12.88) 8.92a
Supportive psychotherapy 29.58 4.22 (28.21–30.95) 21.97 4.51 (20.44–23.50) 2.83a
GDSS Flexible coping psychotherapy 25.45 3.99 (24.04–26.87) 14.91 4.01 (13.51–16.31) 4.25a
Supportive psychotherapy 26.00 4.16 (24.54–27.46) 23.03 4.04 (21.59–24.48) 1.27
Anxiety Flexible coping psychotherapy 58.30 11.54 (54.38–62.23) 32.36 13.16 (28.22–36.51) 5.51a
Supportive psychotherapy 58.13 10.99 (54.08–62.18) 31.42 10.44 (27.14–35.70) 5.75a
a Reliable changes over time.
RCI  reliable change index; SDSS  self-rated dyspeptic symptom severity; GDSS  gastroenterologist-rated dyspeptic symptom severity.
Figure 2. Self-rated dyspeptic symptom severity (SDSS) assessed before and after treatment for the flexible coping psychotherapy (FCP) and supportive
psychotherapy (SPP) groups. Bars indicate 95% confidence intervals.Mnorm indicates normative mean. The gray shaded area shows the normative range of scores
drawn from a community sample of healthy Chinese individuals.
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between the mean score of the FCP group assessed at time 2
and the normative mean fell within the range of closeness
(C.E.t (114)  3.82, p  .0001).
The independent-samples t test examines whether the mean
of a treatment group and that of the healthy community group
are statistically different from each other. Results showed no
statistically significant differences between the mean score of
the FCP group at time 2 and that of the healthy community
group (t (114)  1.09, p  .28). According to Kendall and
colleagues, clinical equivalence is indicated by both a signif-
icant t value in the clinical equivalency test and a nonsignif-
icant t -value in the independent-samples t test. Meeting these
criteria, these two results suggested that only the FCP pro-
duces a practically significant reduction in SDSS 12 months
after treatment. Taken together, the present results provide
support for the effectiveness of FCP in producing a reliable
reduction in dyspeptic symptoms for patients with FD.
DISCUSSION
The present study may contribute to the extant literature in
several ways. Specifically, this study was the first to use a
FCP for enhancing the coping flexibility of patients with FD.
The components of this psychotherapy are derived from pre-
vious findings on FD. More broadly, this project lays out a
systematic structure through the combination of empiric find-
ings and techniques. Adopting this new psychotherapy, the
present study provided tentative support that the FCP pro-
duces both statistically and clinically significant changes in
FD symptom severity.
SPP is currently the most popular approach adopted in
psychological intervention programs for treating FD (22). It
advocates the reduction of symptoms through the provision of
support to empower clients and education materials to en-
hance clients’ understanding of their own health conditions.
While providing the same amount of support and education
materials, the FCP also emphasizes acquisition of techniques
and, more importantly, flexible deployment of distinct tech-
niques to handle specific demands of different stressful situ-
ations and symptom conditions (see (13,14)).
The present study revealed that both the FCP and the SPP
were beneficial in bringing about desirable outcomes for pa-
tients with FD. A comparison of the outcomes yielded by
these psychotherapy programs may foster the identification of
the specific elements of psychotherapy that produce positive
changes in clients. To elaborate, the FCP and the SPP are both
effective in anxiety reduction. Because both psychotherapies
render social support and education materials, the present
results suggest that these two social support elements are
related to long-term changes in anxiety levels.
Compared with the SPP, however, the FCP was found to be
more efficacious in reducing FD symptoms. Only the clients
receiving FCP reported clinical reductions in dyspeptic symp-
tom severity. It is worth noting that such a clinical significance
of change was found to be present 12 months after the psy-
chotherapy program. Such a finding suggests that the tech-
niques learned from the FCP—especially for sensitivity in
distinguishing among distinct stressful events and flexible
application of diverse strategies to handle distinct stressful
situations—can be implemented and integrated into one’s
daily life.
Apart from the SPP, medical intervention is also commonly
adopted for treatment of FD, a common functional gastroen-
terological disorder. Functional gastroenterological disorders
impose a substantial economical burden in terms of medical
consultation and drug costs (36). According to a large-scale
population-based survey on more than 5500 adults across
seven regions of the world (37), 30% of individuals with
functional gastroenterological disorders had taken either over-
the-counter or prescribed drugs. One percent of them reported
having stayed at a hospital for their problems. In the United
States, the annual medical and drug cost of functional gastro-
enterological disorders was an estimated $9.3 billion (38).
Because the FCP was found to be useful in producing positive
therapeutic outcomes, the results may have implications for
primary practice as an alternative to current medical treatment,
thus reducing drug consumption and the financial burden on
primary care services. Future studies should be conducted to
examine possible differences in effectiveness and duration
between the FCP and medical intervention.
Before concluding, several caveats are worth noting. This
study is an initial attempt to examine the efficacy of a new
psychotherapy on treating FD symptoms and thus the present
findings should be regarded as tentative. First, the potential
problem related to the generalizability of findings should be
noted. Specifically, the present sample was limited to patients
with FD who attended the outpatient section of two public
hospitals. Because the presentation of somatic symptoms
for patients who attended walk-in clinics differ from that of
patients who attended private clinics with personal physi-
cians (39), future studies should examine the generalizabil-
ity of the results to patients from a variety of clinic settings,
especially those from private clinics. Also, participants in
this study were all having FD symptoms for at least 3 years.
Further studies should explore the effectiveness of FCP to more
heterogeneous samples such as those with a shorter history of
having FD.
Second, it is important to note that participants in this study
were all ethnically Chinese. Previous studies (40,41) have
shown that the prevalence rates of having functional gastro-
intestinal disorders, the physiological mechanisms influencing
gastrointestinal symptoms, and the psychological profiles of
Chinese patients with functional gastrointestinal disorders
were highly similar to patients from Western countries. How-
ever, the study by Hsu and Folstein (42) revealed that Chinese
American patients tended to report more abnormal sensations,
whereas white patients tended to report more abnormal motor
functions. This study should thus be replicated in other cul-
tural settings, preferably by crosscultural studies, to address
the issue concerning the generalizability of the present results
across cultures.
Third, although the power test showed that the sample size
was adequate, the number of participants in this sample was
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relatively small compared with the population of Chinese
patients. Further studies with a larger sample drawn from a
variety of Chinese populations (e.g., both urban and rural
areas) should be conducted to evaluate whether the present
psychotherapy has the potential to relieve the symptoms of FD
in a diverse group of patients. Moreover, a larger sample size
enables researchers to compare the efficacy of the FCP among
patients with FD with distinct predominant gastrointestinal
problems (e.g., epigastric pain, belching).
Fourth, it is worth noting that the follow-up phase was
conducted 12 months after the participants had received psy-
chotherapy. A limitation of the design of this study is that
intermediate time points were lacking and thus the short-term
effects of the FCP were unknown. Multiple-phase studies
should be conducted to include more time points (such as
immediately after psychotherapy, 3-month follow up) to ex-
amine immediate, short-term, and long-term effectiveness of
the FCP on FD.
To conclude, FD was once a conundrum to researchers,
who attempted to relate the disorder to certain pathogenic
physical mechanisms but failed (see (43)). The growing inter-
est in exploring psychological factors has led to studies that
enhance the understanding of the mechanisms that influence
symptom severity of the disorder. The present study may
provide further insights on possible reductions in FD symp-
toms through the adoption of the FCP.
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